tiprankstipranks
Trending News
More News >
IRLAB Therapeutics AB Class A (SE:IRLAB.A)
:IRLAB.A
Sweden Market
Advertisement

IRLAB Therapeutics AB Class A (IRLAB.A) Ratios

Compare
0 Followers

IRLAB Therapeutics AB Class A Ratios

SE:IRLAB.A's free cash flow for Q1 2025 was kr1.00. For the 2025 fiscal year, SE:IRLAB.A's free cash flow was decreased by kr and operating cash flow was kr-6.51. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.68 3.36 8.31 6.07 13.56
Quick Ratio
0.68 3.36 8.19 6.04 13.47
Cash Ratio
0.58 3.03 7.82 5.79 13.24
Solvency Ratio
-0.47 -2.83 -3.37 0.75 -4.05
Operating Cash Flow Ratio
-0.14 -4.49 -4.41 1.85 -4.26
Short-Term Operating Cash Flow Coverage
-0.35 0.00 0.00 -2.73 18.92
Net Current Asset Value
kr -50.90Mkr 62.23Mkr 235.96Mkr 348.47Mkr 261.55M
Leverage Ratios
Debt-to-Assets Ratio
0.42 0.16 0.01 0.01 <0.01
Debt-to-Equity Ratio
14.35 0.24 0.01 0.02 <0.01
Debt-to-Capital Ratio
0.93 0.19 0.01 0.02 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.17 0.00 0.00 0.00
Financial Leverage Ratio
34.48 1.53 1.11 1.18 1.06
Debt Service Coverage Ratio
-0.80 -870.97 -370.11 -1.18 19.84
Interest Coverage Ratio
-5.06 -908.37 -380.84 142.10 -469.02
Debt to Market Cap
0.19 0.05 0.00 -0.02 >-0.01
Interest Debt Per Share
1.55 0.54 0.08 0.13 0.07
Net Debt to EBITDA
0.37 0.48 2.28 -7.14 3.06
Profitability Margins
Gross Profit Margin
-51.22%-2161.57%-181.94%81.19%-565.67%
EBIT Margin
-64.79%-3128.58%-185.01%25.30%-30485.67%
EBITDA Margin
-60.19%-3052.55%-178.50%26.65%-29820.00%
Operating Profit Margin
-71.26%-3183.60%-185.01%25.30%-30486.00%
Pretax Profit Margin
-78.88%-3132.07%-185.50%24.92%-30551.00%
Net Profit Margin
-78.88%-3132.07%-186.80%24.92%-30616.00%
Continuous Operations Profit Margin
-78.88%-3132.07%-185.50%24.92%-30551.00%
Net Income Per EBT
100.00%100.00%100.70%100.00%100.21%
EBT Per EBIT
110.70%98.38%100.26%98.49%100.21%
Return on Assets (ROA)
-48.88%-100.41%-35.30%10.96%-24.82%
Return on Equity (ROE)
-215.42%-153.62%-39.27%12.96%-26.40%
Return on Capital Employed (ROCE)
-965.29%-128.76%-38.84%13.04%-26.19%
Return on Invested Capital (ROIC)
-99.21%-126.12%-38.64%14.54%-26.48%
Return on Tangible Assets
-69.18%-136.53%-41.27%12.05%-31.89%
Earnings Yield
-43.01%-38.96%-5.75%2.27%-4.59%
Efficiency Ratios
Receivables Turnover
6.35 0.63 5.00 12.20 0.06
Payables Turnover
0.00 12.20 17.18 3.18 0.54
Inventory Turnover
0.00 0.00 46.69 15.58 0.99
Fixed Asset Turnover
11.42 0.85 7.63 24.89 0.07
Asset Turnover
0.62 0.03 0.19 0.44 <0.01
Working Capital Turnover Ratio
-2.88 0.04 0.21 0.68 <0.01
Cash Conversion Cycle
57.47 546.26 59.52 -61.52 5.43K
Days of Sales Outstanding
57.47 576.17 72.94 29.92 5.73K
Days of Inventory Outstanding
0.00 0.00 7.82 23.43 369.02
Days of Payables Outstanding
0.00 29.91 21.24 114.87 673.16
Operating Cycle
57.47 576.17 80.76 53.35 6.10K
Cash Flow Ratios
Operating Cash Flow Per Share
-0.41 -3.18 -2.75 2.49 -1.87
Free Cash Flow Per Share
-0.41 -3.18 -2.82 2.47 -1.88
CapEx Per Share
<0.01 <0.01 0.07 0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.01 1.00 1.02 0.99 1.00
Dividend Paid and CapEx Coverage Ratio
-105.76 -562.63 -42.24 181.70 -226.43
Capital Expenditure Coverage Ratio
-105.76 -562.63 -42.24 181.70 -226.43
Operating Cash Flow Coverage Ratio
-0.32 -5.98 -35.87 19.49 -30.48
Operating Cash Flow to Sales Ratio
-0.21 -29.03 -2.33 0.62 -297.38
Free Cash Flow Yield
-6.70%-36.18%-7.35%5.62%-4.47%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-2.33 -2.57 -17.38 43.97 -21.80
Price-to-Sales (P/S) Ratio
3.20 80.39 32.47 10.96 6.67K
Price-to-Book (P/B) Ratio
39.19 3.94 6.83 5.70 5.76
Price-to-Free Cash Flow (P/FCF) Ratio
-14.93 -2.76 -13.60 17.80 -22.35
Price-to-Operating Cash Flow Ratio
-8.63 -2.77 -13.92 17.70 -22.45
Price-to-Earnings Growth (PEG) Ratio
-0.37 -0.05 0.05 -0.29 1.27
Price-to-Fair Value
39.19 3.94 6.83 5.70 5.76
Enterprise Value Multiple
-4.95 -2.15 -15.91 33.99 -19.32
Enterprise Value
295.06M 372.70M 1.74B 1.88B 1.73B
EV to EBITDA
-4.95 -2.15 -15.91 33.99 -19.32
EV to Sales
2.98 65.64 28.40 9.06 5.76K
EV to Free Cash Flow
-13.89 -2.26 -11.89 14.71 -19.29
EV to Operating Cash Flow
-14.02 -2.26 -12.18 14.63 -19.37
Tangible Book Value Per Share
0.09 1.33 4.71 6.90 5.58
Shareholders’ Equity Per Share
0.09 2.23 5.61 7.72 7.30
Tax and Other Ratios
Effective Tax Rate
>-0.01 0.00 >-0.01 <0.01 >-0.01
Revenue Per Share
1.91 0.11 1.18 4.02 <0.01
Net Income Per Share
-1.51 -3.43 -2.20 1.00 -1.93
Tax Burden
1.00 1.00 1.01 1.00 1.00
Interest Burden
1.22 1.00 1.00 0.98 1.00
Research & Development to Revenue
0.88 26.65 2.39 0.19 254.16
SG&A to Revenue
0.00 0.00 2.06 0.39 218.77
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.29 0.93 1.26 2.45 0.98
Currency in SEK
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis